Literature DB >> 24048529

Comparison of the Simplexa FluA/B & RSV direct assay and laboratory-developed real-time PCR assays for detection of respiratory virus.

Mitchell W Woodberry1, Rohit Shankar, Anne Cent, Keith R Jerome, Jane Kuypers.   

Abstract

The results of the Focus Simplexa FluA/B & RSV Direct assay were compared to those of laboratory-developed reverse transcription PCR tests for 498 nasopharyngeal swabs. Concordance rates were 96.6% (476/493; κ = 0.91), 97.6% (481/493; κ = 0.47), and 99.2% (488/492; κ = 0.94) for influenza A, influenza B, and respiratory syncytial virus, respectively.

Entities:  

Mesh：

Year:  2013        PMID： 24048529      PMCID： PMC3889790          DOI： 10.1128/JCM.02395-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  Evaluation of Simplexa Flu A/B & RSV for direct detection of influenza viruses (A and B) and respiratory syncytial virus in patient clinical samples.

Authors:  Musa Hindiyeh; Liat Kolet; Tal Meningher; Merav Weil; Ella Mendelson; Michal Mandelboim
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

Review 2.  Accuracy of rapid influenza diagnostic tests: a meta-analysis.

Authors:  Caroline Chartrand; Mariska M G Leeflang; Jessica Minion; Timothy Brewer; Madhukar Pai
Journal:  Ann Intern Med       Date:  2012-02-27       Impact factor: 25.391

3.  Comparative evaluation of the Nanosphere Verigene RV+ assay and the Simplexa Flu A/B & RSV kit for detection of influenza and respiratory syncytial viruses.

Authors:  Kevin Alby; Elena B Popowitch; Melissa B Miller
Journal:  J Clin Microbiol       Date:  2012-11-14       Impact factor: 5.948

4.  Performance of six influenza rapid tests in detecting human influenza in clinical specimens.

Authors:  Aeron C Hurt; Robert Alexander; Jan Hibbert; Nicola Deed; Ian G Barr
Journal:  J Clin Virol       Date:  2007-04-23       Impact factor: 3.168

5.  Comparison of a multiplex real-time PCR assay with a multiplex Luminex assay for influenza virus detection.

Authors:  Sandra B Munro; Jane Kuypers; Keith R Jerome
Journal:  J Clin Microbiol       Date:  2013-01-23       Impact factor: 5.948

6.  Comparison of viral isolation and multiplex real-time reverse transcription-PCR for confirmation of respiratory syncytial virus and influenza virus detection by antigen immunoassays.

Authors:  R S Liao; L L Tomalty; A Majury; D E Zoutman
Journal:  J Clin Microbiol       Date:  2009-01-07       Impact factor: 5.948

7.  Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus.

Authors:  Jan Felix Drexler; Angelika Helmer; Heike Kirberg; Ulrike Reber; Marcus Panning; Marcel Müller; Katja Höfling; Bertfried Matz; Christian Drosten; Anna Maria Eis-Hübinger
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

8.  Evaluation of quantitative and type-specific real-time RT-PCR assays for detection of respiratory syncytial virus in respiratory specimens from children.

Authors:  Jane Kuypers; Nancy Wright; Rhoda Morrow
Journal:  J Clin Virol       Date:  2004-10       Impact factor: 3.168
  8 in total
  12 in total

1.  Comparison of Simplexa Flu A/B & RSV PCR with cytospin-immunofluorescence and laboratory-developed TaqMan PCR in predominantly adult hospitalized patients.

Authors:  Marie L Landry; David Ferguson
Journal:  J Clin Microbiol       Date:  2014-05-21       Impact factor: 5.948

2.  Rhinovirus Disease in Children Seeking Care in a Tertiary Pediatric Emergency Department.

Authors:  Helen Y Chu; Janet A Englund; Bonnie Strelitz; Kirsten Lacombe; Charla Jones; Kristin Follmer; Emily K Martin; Miranda Bradford; Xuan Qin; Jane Kuypers; Eileen J Klein
Journal:  J Pediatric Infect Dis Soc       Date:  2014-10-19       Impact factor: 3.164

3.  Impact of Rapid Molecular Detection of Respiratory Viruses on Clinical Outcomes and Patient Management.

Authors:  Jane Kuypers
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

4.  Impact of rapid influenza PCR testing on hospitalization and antiviral use: A retrospective cohort study.

Authors:  Helen Y Chu; Janet A Englund; Dandi Huang; Emily Scott; Jeanne D Chan; Rupali Jain; Paul S Pottinger; John B Lynch; Timothy H Dellit; Keith R Jerome; Jane Kuypers
Journal:  J Med Virol       Date:  2015-06-12       Impact factor: 2.327

Review 5.  Sample-to-result molecular infectious disease assays: clinical implications, limitations and potential.

Authors:  Stacy G Beal; Naziheh Assarzadegan; Kenneth H Rand
Journal:  Expert Rev Mol Diagn       Date:  2016-01-11       Impact factor: 5.225

Review 6.  [Rapid diagnostic test for respiratory infections].

Authors:  José María Marimón; José María Navarro-Marí
Journal:  Enferm Infecc Microbiol Clin       Date:  2017-01-03       Impact factor: 1.731

Review 7.  Rapid diagnosis of influenza: state of the art.

Authors:  David R Peaper; Marie L Landry
Journal:  Clin Lab Med       Date:  2014-06       Impact factor: 1.935

8.  Analytical performance of the Alere™ i Influenza A&B assay for the rapid detection of influenza viruses.

Authors:  Cristina Riazzo; Mercedes Pérez-Ruiz; Sara Sanbonmatsu-Gámez; Irene Pedrosa-Corral; José Gutiérrez-Fernández; José-María Navarro-Marí
Journal:  Enferm Infecc Microbiol Clin       Date:  2015-11-25       Impact factor: 1.731

9.  Performance evaluation of direct fluorescent antibody, Focus Diagnostics Simplexa™ Flu A/B & RSV and multi-parameter customized respiratory Taqman® array card in immunocompromised patients.

Authors:  Deborah Steensels; Marijke Reynders; Patrick Descheemaeker; Martin D Curran; Frédérique Jacobs; Olivier Denis; Marie-Luce Delforge; Isabel Montesinos
Journal:  J Virol Methods       Date:  2017-03-30       Impact factor: 2.014

10.  Respiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study.

Authors:  Cheryl Volling; Kazi Hassan; Tony Mazzulli; Karen Green; Ahmed Al-Den; Paul Hunter; Rupi Mangat; John Ng; Allison McGeer
Journal:  BMC Infect Dis       Date:  2014-12-13       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.